Suppr超能文献

急诊科中重度哮喘急性发作儿童的管理

Management of children with severe asthma exacerbation in the emergency department.

作者信息

Volovitz Benjamin, Nussinovitch Moshe

机构信息

Asthma Clinic, Schneider Children's Medical Center of Israel, and Sackler School of Medicine, Tel Aviv University, Petah Tikva, Tel Aviv, Israel.

出版信息

Paediatr Drugs. 2002;4(3):141-8. doi: 10.2165/00128072-200204030-00001.

Abstract

Although acute asthma is a very common cause of emergency department visits in children, there is as yet insufficient evidence for the establishment of a standardized treatment protocol. The aim of this review is to describe updated information on the management of asthma exacerbations in the pediatric emergency department. Oxygen is the first-line treatment of acute asthma exacerbations in the emergency department to control hypoxemia. It is accompanied by the administration of beta(2)-adrenoceptor agonists followed by corticosteroids. beta(2)-Adrenoceptor agonists have traditionally been administered by nebulization, although spacers have recently been introduced and proven, in many cases, to be as effective as nebulization. Oral prednisolone, with its reliability, simplicity, convenience and low cost, should remain the treatment of choice for the most severe asthma exacerbations, when the lung airways are extremely contracted and filled with secretions. Recently, several studies have shown that high-dose inhaled corticosteroids are at least as effective as oral corticosteroids in controlling moderate to severe asthma attacks in children and therefore should be considered an alternative treatment to oral corticosteroids in moderate to severe asthma attacks. Studies of other drugs have shown that ipratropium bromide may be given only in addition to beta(2)-adrenoceptor agonists; theophylline has no additional benefit, and magnesium sulfate has no clear advantage. Comprehensive asthma management should also include asthma education, measures to prevent asthma triggers, and training in the use of inhalers and spacers. Proper management will avoid most asthma attacks and reduce admission and readmission to emergency departments.

摘要

尽管急性哮喘是儿童急诊就诊的常见原因,但目前尚无足够证据来制定标准化治疗方案。本综述的目的是描述儿科急诊科哮喘加重期管理的最新信息。氧气是急诊科急性哮喘加重期控制低氧血症的一线治疗方法。同时会给予β₂肾上腺素能受体激动剂,随后给予皮质类固醇。传统上,β₂肾上腺素能受体激动剂通过雾化给药,不过最近引入了储雾罐,并且在许多情况下已证明其与雾化效果相同。口服泼尼松龙具有可靠性、简便性、便利性和低成本等特点,当肺气道极度收缩且充满分泌物时,对于最严重的哮喘加重期,它仍应是首选治疗药物。最近,多项研究表明,高剂量吸入皮质类固醇在控制儿童中度至重度哮喘发作方面至少与口服皮质类固醇一样有效,因此在中度至重度哮喘发作时应被视为口服皮质类固醇的替代治疗方法。对其他药物的研究表明,异丙托溴铵仅可在β₂肾上腺素能受体激动剂基础上加用;茶碱并无额外益处,硫酸镁也无明显优势。全面的哮喘管理还应包括哮喘教育、预防哮喘诱发因素的措施以及吸入器和储雾罐使用培训。恰当的管理将避免大多数哮喘发作,并减少急诊入院和再次入院情况。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验